The implantation of gentamicin polymethylmethacrylate (PMMA) chains or mini
chains into infected osteomyelitic cavities is a well-established local ant
ibiotic therapy supplementary to radical debridement. The gentamicin concen
trations achieved at the site of infection are far above the MICs for most
common pathogens in chronic osteomyelitis. Serum and urine concentrations a
re low and nephrotoxic and ototoxic side-effects of this form of gentamicin
application are not to be feared. Under local antibiotic therapy with gent
amicin PMMA chains, primary wound healing as in aseptic surgery can be expe
cted. Prolonged systemic antibiotic therapy is unnecessary. In a series of
405 cases, a success rate of 90.4% was obtained.